$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Colon Cancer - Pipeline Review, H1 2017 [Report Updated: 30-06-2017]

Published by Global Markets Direct: 30 Jun 2017 | 100098 | In Stock

Introduction

Colon Cancer - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer - Pipeline Review, H1 2017, provides an overview of the Colon Cancer (Oncology) pipeline landscape.

Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Colon Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Colon Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Colon Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colon Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 12, 35, 4, 168 and 21 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 3, 44 and 16 molecules, respectively.

Colon Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Colon Cancer (Oncology).

- The pipeline guide reviews pipeline therapeutics for Colon Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Colon Cancer (Oncology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Colon Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Colon Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Colon Cancer (Oncology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Colon Cancer (Oncology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
for Colon Cancer - Pipeline Review, H1 2017 [Report Updated: 30-06-2017]

  • Table of Contents

    Table of Contents 2

    Introduction 7

    Colon Cancer - Overview 8

    Colon Cancer - Therapeutics Development 9

    Colon Cancer - Therapeutics Assessment 42

    Colon Cancer - Companies Involved in Therapeutics Development 64

    Colon Cancer - Drug Profiles 136

    Colon Cancer - Dormant Projects 692

    Colon Cancer - Discontinued Products 703

    Colon Cancer - Product Development Milestones 704

    Appendix 714

Additional Details

Publisher

Global Markets Direct

Publisher Information

Reference

100098 | GMDHC9471IDB

Number of Pages

745

Report Format

PDF

Global Markets Direct Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global and Chinese Colon therapy machine Industry, 2017 Market Research Report
The 'Global and Chinese Colon therapy machine Industry, 2012-2022 Market Research Report' is a profe...
15 Dec 2017 by Prof Research USD $3,000 More Info
Colon Capsule Endoscopy-China Market Status and Trend Report 2013-2023
Report SummaryColon Capsule Endoscopy-Asia Pacific Market Status and Trend Report 2013-2023 offers a...
23 Oct 2017 by MIReports USD $3,480 More Info
Colon Capsule Endoscopy-EMEA Market Status and Trend Report 2013-2023
Report SummaryColon Capsule Endoscopy-Europe Market Status and Trend Report 2013-2023 offers a compr...
23 Oct 2017 by MIReports USD $3,480 More Info
Colon Capsule Endoscopy-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report SummaryColon Capsule Endoscopy-Global Market Status and Trend Report 2013-2023 offers a compr...
23 Oct 2017 by MIReports USD $2,480 More Info
Colon Capsule Endoscopy-Global Market Status and Trend Report 2013-2023
Report SummaryDrug-delivery Smart Pill-United States Market Status and Trend Report 2013-2023 offers...
23 Oct 2017 by MIReports USD $3,480 More Info
Colon Cancer Global Clinical Trials Review, H1, 2017
Colon Cancer Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Colo...
30 Jun 2017 by Global Data USD $2,500 More Info
Colon Carcinoma-Pipeline Insights, 2017
DelveInsight’s, “ Colon Carcinoma-Pipeline Insights, 2017”, report provides in depth insights on the...
30 May 2017 by Delve Insight USD $1,250 More Info
Colon Tumor-Pipeline Insights, 2017
DelveInsight’s, “ Colon Tumor-Pipeline Insights, 2017”, report provides in depth insights on the pip...
30 May 2017 by Delve Insight USD $1,250 More Info
Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscap...
30 May 2017 by Delve Insight USD $2,000 More Info
Colon Cancer - Pipeline Review, H2 2016
Colon Cancer - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Heal...
30 Dec 2016 by Global Markets Direct USD $2,500 More Info

This report is published by Global Markets Direct

Download Free Report Summary PDF

Colon Cancer - Pipeline Review, H1 2017 [Report Updated: 30-06-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data